Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Colatsky, C. Follmer, C. Starmer, T. Colatsky (1990)
Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias.Circulation, 82 6
H. Bryson, K. Palmer, H. Langtry, A. Fitton (2012)
PropafenoneDrugs, 45
D. Mays, J. Foose, L. Philipson, M. Tamkun (1995)
Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.The Journal of clinical investigation, 96 1
F. Ledda, L. Mantelli, S. Manzini, S. Amerini, A. Mugelli (1981)
Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 3
John Lee, Heyo Kroemer, D. Silberstein, Christian Funck-Brentano, Mark Lineberry, Alastair Wood, D. Roden, R Woosley (1990)
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.The New England journal of medicine, 322 25
A. Woodhull (1973)
Ionic Blockage of Sodium Channels in NerveThe Journal of General Physiology, 61
L. Fei, J. Gill, W. McKenna, A. Camm (1993)
Effects of propafenone on calcium currents in single ventricular myocytes of guinea‐pigBritish Journal of Pharmacology, 109
I. Dukes, E. Williams (1984)
The multiple modes of action of propafenone.European heart journal, 5 2
D. Rampe, B. Wible, D. Fedida, R. Dage, A. Brown (1993)
Verapamil blocks a rapidly activating delayed rectifier K+ channel cloned from human heart.Molecular pharmacology, 44 3
J. Snyders, K. Knoth, S. Roberds, M. Tamkun (1992)
Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.Molecular pharmacology, 41 2
W. Boyle, J. Nerbonne (1991)
A novel type of depolarization-activated K+ current in isolated adult rat atrial myocytes.The American journal of physiology, 260 4 Pt 2
C. Valenzuela, E. Delpón, L. Franqueza, Pilar Gay, D. Snyders, J. Tamargo (1997)
Effects of Ropivacaine on a Potassium Channel (hKv1.5) Cloned from Human VentricleAnesthesiology, 86
Funck-brentano (1990)
PropafenoneN. Engl. J. Med., 322
Rampe (1993b)
Verapamil blocks a rapidly activating delayed K + channel cloned from human heartMol Pharmacol., 4
C. Jeck, P. Boyden (1992)
Age-related appearance of outward currents may contribute to developmental differences in ventricular repolarization.Circulation research, 71 6
H. Konarzewska, G. Peeters, Michael Sanguinetti (1995)
Repolarizing K+ currents in nonfailing human hearts. Similarities between right septal subendocardial and left subepicardial ventricular myocytes.Circulation, 92 5
H. Satoh, K. Hashimoto (1984)
Effect of propafenone on the membrane currents of rabbit sino-atrial node cells.European journal of pharmacology, 99 2-3
Dirk Snyders, M. Tamkun, Paul Bennett (1993)
A rapidly activating and slowly inactivating potassium channel cloned from human heart. Functional analysis after stable mammalian cell culture expressionThe Journal of General Physiology, 101
E. Delpón, C. Valenzuela, O. Pérez, L. Franqueza, Pilar Gay, D. Snyders, J. Tamargo (1996)
Mechanisms of block of a human cloned potassium channel by the enantiomers of a new bradycardic agent: S‐16257‐2 and S‐16260‐2British Journal of Pharmacology, 117
M. Chimienti, M. Cullen, G. Casadei, Propafenone Investigators (1996)
Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.The American journal of cardiology, 77 3
C. Valenzuela, E. Delpón, J. Tamargo (1988)
Tonic and Phasic Vmax Block Induced by 5‐Hydroxypropafenone in Guinea Pig Ventricular MusclesJournal of Cardiovascular Pharmacology, 12
K. Deal, S. England, M. Tamkun (1996)
Molecular physiology of cardiac potassium channels.Physiological reviews, 76 1
Zhiguo Wang, B. Fermini, S. Nattel (1993)
Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.Circulation research, 73 6
D. Harron, R. Brogden (1987)
Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.Drugs, 34 6
C. Valenzuela, C. Delgado, J. Tamargo (1987)
Electrophysiological Effects of 5‐Hydroxypropafenone on Guinea Pig Ventricular Muscle FibresJournal of Cardiovascular Pharmacology, 10
Hege (1984)
The metabolic fate of 2H-labelled propafenone in manEur. J. Drug Metab. Pharmacokin., 9
C. Funck-Brentano, H. Kroemer, John Lee, D. Roden (1990)
Drug therapy : propafenoneThe New England Journal of Medicine, 322
Boyle (1991)
A novel type of depolarization-activated K+ current in adult rat atrial myocytesAm. J. Physiol., 260
A. Mcleod, G. Stiles, D. Shand (1984)
Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.The Journal of pharmacology and experimental therapeutics, 228 2
Dirk Snyders, Sarita Yeola (1995)
Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.Circulation research, 77 3
Kathleen Choi, C. Mossman, J. Aubé, G. Yellen (1993)
The internal quaternary ammonium receptor site of Shaker potassium channelsNeuron, 10
G. Malfatto, A. Zaza, M. Forster, B. Sodowick, P. Danilo, M. Rosen (1988)
Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.The Journal of pharmacology and experimental therapeutics, 246 2
D. Roden (1993)
Current status of class III antiarrhythmic drug therapy.The American journal of cardiology, 72 6
Hamill (1981)
Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patchesPflügers. Arch., 391
G. Li, J. Feng, Z. Wang, B. Fermini, S. Nattel (1996)
Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes.Circulation research, 78 5
D. Rampe, B. Wible, A. Brown, R. Dage (1993)
Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart.Molecular pharmacology, 44 6
T. Yang, C. Prakash, D. Roden, D. Snyders (1995)
Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomersBritish Journal of Pharmacology, 115
G. Yellen, M. Jurman, Tatiana Abramson, R. MacKinnon (1991)
Mutations affecting internal TEA blockade identify the probable pore-forming region of a K+ channelScience, 251
J. Kingma, M. Suttorp (1992)
Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.The American journal of cardiology, 70 5
R. Latini, E. Barbieri, C. Castello, S. Marchi, A. Sica, G. Gerosa, R. Rossi, P. Zardini (1989)
Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery.American heart journal, 117 2
(1995)
A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial ®brillation
C. Valenzuela, E. Delpón, L. Franqueza, P. Gay, O. Pérez, J. Tamargo, D. Snyders (1996)
Class III antiarrhythmic effects of zatebradine. Time-, state-, use-, and voltage-dependent block of hKv1.5 channels.Circulation, 94 3
A. Gillis, R. Kates (1986)
Myocardial uptake kinetics and pharmacodynamics of propafenone in the isolated perfused rabbit heart.The Journal of pharmacology and experimental therapeutics, 237 3
R. Caballero, E. Delpón, C. Valenzuela, M. Longobardo, L. Franqueza, J. Tamargo (1997)
Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5British Journal of Pharmacology, 122
E. Delpón, C. Valenzuela, O. Pérez, Ó. Casis, J. Tamargo (1995)
Propafenone preferentially blocks the rapidly activating component of delayed rectifier K+ current in guinea pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component.Circulation research, 76 2
D. Duan, B. Fermini, S. Nattel (1993)
Potassium channel blocking properties of propafenone in rabbit atrial myocytes.The Journal of pharmacology and experimental therapeutics, 264 3
C. Delgado, J. Tamargo, T. Tejerina, C. Valenzuela (1987)
Effects of 5‐hydroxy‐propafenone in guinea‐pig atrial fibresBritish Journal of Pharmacology, 90
Kishore (1995)
Guidelines for the use of propafenone in treating supraventricular arrhythmiasDrugs, 50
C. Delgado, J. Tamargo, D. Henzel, P. Lorente (1993)
Effects of propafenone on calcium current in guinea‐pig ventricular myocytesBritish Journal of Pharmacology, 108
R. Kates, Y. Yee, R. Winkle (1985)
Metabolite cumulation during chronic propafenone dosing in arrhythmiaClinical Pharmacology & Therapeutics, 37
C. Delgado, J. Tamargo, T. Tejerina (1985)
Electrophysiological effects of propafenone in untreated and propafenone‐pretreated guinea‐pig atrial and ventricular muscle fibresBritish Journal of Pharmacology, 86
J. Porterfield, L. Porterfield (1989)
Therapeutic efficacy and safety of oral propafenone for atrial fibrillation.The American journal of cardiology, 63 1
Carmen Valenzuela, E. Delpón, M. Tamkun, J. Tamargo, D. Snyders (1995)
Stereoselective block of a human cardiac potassium channel (Kv1.5) by bupivacaine enantiomers.Biophysical journal, 69 2
M. Slawsky, N. Castle (1994)
K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.The Journal of pharmacology and experimental therapeutics, 269 1
G. Philipsborn, J. Gries, H. Hofmann, H. Kreiskott, R. Kretzschmar, C. Müller, M. Raschack, H. Teschendorf (1984)
Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.Arzneimittel-Forschung, 34 11
S. Cobbe (1994)
Drug therapy of supraventricular tachyarrhythmias--based on efficacy or futility?European heart journal, 15 Suppl A
K. Thompson, D. Iansmith, L. Siddoway, R. Woosley, D. Roden (1988)
Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.The Journal of pharmacology and experimental therapeutics, 244 3
L. Siddoway, K. Thompson, C. Mcallister, T. Wang, G. Wilkinson, D. Roden, R. Woosley (1987)
Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences.Circulation, 75 4
C. Gentili, Filippo Giordano, A. Alois, E. Massa, L. Bianconi (1992)
Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery.American heart journal, 123 5
L. Hondeghem, D. Snyders (1990)
Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.Circulation, 81 2
M. Tamkun, K. Knoth, Julia Walbridge, H. Kroemer, D. Roden, Deborah Glover (1991)
Molecular cloning and characterization of two voltage‐gated K+ channel cDNAs from human ventricleThe FASEB Journal, 5
1 The goal of this study was to analyse the effects of propafenone and its major metabolite, 5‐hydroxy‐propafenone, on a human cardiac K+ channel (hKv1.5) stably expressed in Ltk− cells and using the whole‐cell configuration of the patch‐clamp technique. 2 Propafenone and 5‐hydroxy‐propafenone inhibited in a concentration‐dependent manner the hKv1.5 current with KD values of 4.4±0.3 μM and 9.2±1.6 μM, respectively. 3 Block induced by both drugs was voltage‐dependent consistent with a value of electrical distance (referenced to the cytoplasmic side) of 0.17±0.55 (n=10) and 0.16±0.81 (n=16). 4 The apparent association (k) and dissociation (l) rate constants for propafenone were (8.9±0.9)×106 M−1 s−1 and 39.5±4.2 s−1, respectively. For 5‐hydroxy‐propafenone these values averaged (2.3±0.3)×106 M−1 s−1 and 21.4±3.1 s−1, respectively. 5 Both drugs reduced the tail current amplitude recorded at −40 mV after 250 ms depolarizing pulses to +60 mV, and slowed the deactivation time course resulting in a ‘crossover’ phenomenon when the tail currents recorded under control conditions and in the presence of each drug were superimposed. 6 Both compounds induced a small but statistically significant use‐dependent block when trains of depolarizations at frequencies between 0.5 and 3 Hz were applied. 7 These results indicate that propafenone and its metabolite block hKv1.5 channels in a concentration‐, voltage‐, time‐ and use‐dependent manner and the concentrations needed to observe these effects are in the therapeutical range.
British Journal of Pharmacology – Wiley
Published: Nov 1, 1998
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.